Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-07-01 18:25:05 ET · period of report 2026-06-29 · accession 0001610717-26-000311 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-01 18:25 | 2026-06-29 | RVMD | Patel Sushil | Dir | M - OptEx | $37.54 | +2,955 | 27.2K | +12% | +$110.9K |
| DMT | 2026-07-01 18:25 | 2026-06-29 | RVMD | Patel Sushil | Dir | S - Sale+OE | $187.99 | -5,580 | 21.7K | -20% | -$1.05M |
| DT | 2026-07-01 18:25 | 2026-06-29 | RVMD | Patel Sushil | Dir | M - OptEx | $0.00 | -2,955 | 13.0K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-29 | M | A | 2,955 | $37.54 | 27,236 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F2) Includes 1,191 restricted stock units. |
| 2 | Common | Common Stock | 2026-06-29 | S | D | 300 | $183.17 | 26,936 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F3) The transaction was executed in multiple trades in prices ranging from $182.93 to $183.54, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 1,191 restricted stock units. |
| 3 | Common | Common Stock | 2026-06-29 | S | D | 900 | $184.59 | 26,036 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F4) The transaction was executed in multiple trades in prices ranging from $184.08 to $184.98, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 1,191 restricted stock units. |
| 4 | Common | Common Stock | 2026-06-29 | S | D | 1,100 | $185.90 | 24,936 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F5) The transaction was executed in multiple trades in prices ranging from $185.37 to $186.35, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 1,191 restricted stock units. |
| 5 | Common | Common Stock | 2026-06-29 | S | D | 858 | $186.92 | 24,078 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F6) The transaction was executed in multiple trades in prices ranging from $186.38 to $187.35, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 1,191 restricted stock units. |
| 6 | Common | Common Stock | 2026-06-29 | S | D | 300 | $187.83 | 23,778 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F7) The transaction was executed in multiple trades in prices ranging from $187.46to $188.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 1,191 restricted stock units. |
| 7 | Common | Common Stock | 2026-06-29 | S | D | 100 | $188.57 | 23,678 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F2) Includes 1,191 restricted stock units. |
| 8 | Common | Common Stock | 2026-06-29 | S | D | 600 | $190.54 | 23,078 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F8) The transaction was executed in multiple trades in prices ranging from $190.44 to $190.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 1,191 restricted stock units. |
| 9 | Common | Common Stock | 2026-06-29 | S | D | 541 | $191.87 | 22,537 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F9) The transaction was executed in multiple trades in prices ranging from $191.47 to $192.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 1,191 restricted stock units. |
| 10 | Common | Common Stock | 2026-06-29 | S | D | 881 | $192.61 | 21,656 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F10) The transaction was executed in multiple trades in prices ranging from $192.55 to $192.64, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 1,191 restricted stock units. |
| 11 | Derivative | Stock Option (Right to Buy) | 2026-06-29 | M | D | 2,955 | $0.00 | 13,000 | D | $37.54 · — to 2034-06-19 | 2,955 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026. (F11) Fully vested. |